For many people, mornings are better than evenings
Genotypes were established using TaqMan assays targeting PNPLA3 rs738409, FADS1 rs174556, and FADS2 rs174583
Results: APAP treatment induced the hepatic S - sulfinylation level in vitro and in vivo
Co-occurring symptom clusters emerged, with Cluster 1 encompassing a mix of somatic and psychological symptoms (such as allergies, anxiety, and hypertension), Cluster 2 encompassing neuromuscular and metabolic symptoms (such as dehydration, headache, and hypoglycemia), and Cluster 3 focusing on gastrointestinal distress
FDA action reinforces that compounded GLP-1 alternatives are not approved drugs Hims & Hers retreat highlights the business risk when regulatory and legal interests collide with aggressive medical marketing Novo Nordisks lawsuit underscores how intellectual property protections are being actively enforced in the GLP-1 market